4 245

Cited 22 times in

CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype

Authors
 Kyu Sub Kang  ;  Yoon Pyo Choi  ;  Ming-Qing Gao  ;  Suki Kang  ;  Baek Gil Kim  ;  Joo Hyun Lee  ;  Mi Jeong Kwon  ;  Young Kee Shin  ;  Nam Hoon Cho 
Citation
 Biochemical and Biophysical Research Communications, Vol.432(2) : 333-338, 2013 
Journal Title
 Biochemical and Biophysical Research Communications 
ISSN
 0006-291X 
Issue Date
2013
Abstract
We recently reported that the subset of CD24+ cells in ovarian cancer possesses various cancer stem cell properties. In this study, we further show that this subpopulation of ovarian cancer cells exhibits an epithelial–mesenchymal transition (EMT) phenotype, high invasive capacity, and CXCR4/SDF-1-mediated chemotactic migration. We evaluated CD24 expression in various ovarian cancer cell lines by flow cytometric analysis. CAOV3 and a primary ovarian cancer cell line Clone 4 were sorted into CD24+ and CD24− subpopulations by FACS and Western blot, cell invasion, adhesion, and in vitro chemotaxis assays were performed with these two subpopulations. We also assessed the effects of shRNA depletion of CD24 in CAOV3 and Clone 4 cells by Western blot and cell invasion assays. CD24 expression in ovarian cancer cell lines correlated with aggressive histologic subtypes of epithelial ovarian cancer. The CD24+ subpopulation was also more invasive than the CD24− subpopulation and showed higher CXCR4/SDF-1-mediated chemotactic migration. CD24+ cells exhibited an EMT phenotype as characterized by loss of E-cadherin expression and gain of vimentin, Twist, and Snail1 expression. In addition, CD24+ cells stimulated cell attachment to fibronectin through the activation of β1 integrin. Depletion of CD24 expression by CD24 shRNA efficiently suppressed cell invasion and induced downregulation of CXCR4 as well as loss of the EMT phenotype. In conclusion, CD24 expression in ovarian cancer may be related to tumor aggressiveness, in particular cell invasion and chemotactic migration. Therefore, CD24 may be a good candidate for a therapeutic target for ovarian cancer.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/86701
DOI
10.1016/j.bbrc.2013.01.102
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > BioMedical Science Institute (의생명과학부)
Yonsei Authors
강규섭(Kang, Kyu Sub)
강숙희(Kang, Suki)
고명청(Gao, Ming Qing)
김백길(Kim, Baek Gil)
이주현(Lee, Joo Hyun)
조남훈(Cho, Nam Hoon)
최윤표(Choi, Yoon Pyo)
사서에게 알리기
  feedback
Full Text
http://www.sciencedirect.com/science/article/pii/S0006291X13001927
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse